Alastair Ray looks at how a brand comms PRO at AstraZeneca sets next year's strategy
PRWeek's first ever roundtable on healthcare PR drew leading industry figures - from both agencies...ble debate for the healthcare PR sector comes at a time when the industry is witnessing great ...
Drug firms are boosting their reputations by preferential pricing, writes Mary Cowlett.
After a year-long debate, Nick Purdom examines the implications of the EC review on DTC and finds that while reform is necessary, critics contend the proposals are inadequate.
Nick Purdom reports on one of the few mature direct to consumer healthcare PR markets....and services,' explains Johnstone. The DTC debate continues while healthcare PR practitioners in the ...
Client: Action Research PR Team: In-house Campaign: Raising Awareness About Research Into the Effects on Children of Untested and Unlicensed Medicines Timescale: December 2000 - September 2002 Budget: Undisclosed
to remove filters